A detailed history of Shell Asset Management CO transactions in Repligen Corp stock. As of the latest transaction made, Shell Asset Management CO holds 715 shares of RGEN stock, worth $107,771. This represents 0.0% of its overall portfolio holdings.

Number of Shares
715
Previous 715 -0.0%
Holding current value
$107,771
Previous $106,000 2.83%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$119.79 - $167.35 $318,162 - $444,481
-2,656 Reduced 78.79%
715 $106,000
Q1 2024

Jul 31, 2024

SELL
$170.78 - $208.42 $55,161 - $67,319
-323 Reduced 8.74%
3,371 $425,000
Q1 2024

May 14, 2024

SELL
$170.78 - $208.42 $354,880 - $433,096
-2,078 Reduced 36.0%
3,694 $679,000
Q4 2023

Feb 14, 2024

SELL
$114.17 - $185.35 $291,818 - $473,754
-2,556 Reduced 30.69%
5,772 $1.04 Million
Q3 2023

Nov 08, 2023

SELL
$138.78 - $176.51 $25,396 - $32,301
-183 Reduced 2.15%
8,328 $1.32 Million
Q2 2023

Jul 28, 2023

BUY
$138.42 - $180.31 $416,090 - $542,011
3,006 Added 54.6%
8,511 $1.2 Million
Q1 2023

May 15, 2023

SELL
$154.26 - $198.1 $1,542 - $1,981
-10 Reduced 0.18%
5,505 $927,000
Q4 2022

Feb 07, 2023

BUY
$162.42 - $220.56 $343,031 - $465,822
2,112 Added 62.06%
5,515 $934,000
Q3 2022

Nov 14, 2022

SELL
$160.42 - $256.21 $143,255 - $228,795
-893 Reduced 20.79%
3,403 $637,000
Q2 2022

Aug 09, 2022

BUY
$140.68 - $188.02 $984 - $1,316
7 Added 0.16%
4,296 $698,000
Q1 2022

May 04, 2022

SELL
$161.19 - $257.96 $102,033 - $163,288
-633 Reduced 12.86%
4,289 $807,000
Q4 2021

Feb 09, 2022

BUY
$247.59 - $304.47 $6,932 - $8,525
28 Added 0.57%
4,922 $1.3 Million
Q3 2021

Nov 04, 2021

SELL
$194.77 - $324.21 $40,901 - $68,084
-210 Reduced 4.11%
4,894 $1.41 Million
Q2 2021

Aug 12, 2021

BUY
$165.87 - $220.95 $46,443 - $61,866
280 Added 5.8%
5,104 $1.02 Million
Q1 2021

May 10, 2021

SELL
$180.37 - $226.26 $5,411 - $6,787
-30 Reduced 0.62%
4,824 $938,000
Q4 2020

Feb 16, 2021

SELL
$148.08 - $206.57 $402,777 - $561,870
-2,720 Reduced 35.91%
4,854 $930,000
Q3 2020

Nov 13, 2020

BUY
$122.51 - $158.27 $53,659 - $69,322
438 Added 6.14%
7,574 $1.12 Million
Q2 2020

Aug 10, 2020

SELL
$94.33 - $140.48 $6,508 - $9,693
-69 Reduced 0.96%
7,136 $882,000
Q1 2020

May 11, 2020

SELL
$84.96 - $109.14 $9,345 - $12,005
-110 Reduced 1.5%
7,205 $696,000
Q4 2019

Feb 13, 2020

SELL
$73.84 - $93.08 $11,223 - $14,148
-152 Reduced 2.04%
7,315 $677,000
Q3 2019

Nov 12, 2019

SELL
$76.65 - $95.51 $4,905 - $6,112
-64 Reduced 0.85%
7,467 $573,000
Q2 2019

Aug 12, 2019

SELL
$54.2 - $85.95 $9,376 - $14,869
-173 Reduced 2.25%
7,531 $647,000
Q4 2018

Feb 13, 2019

SELL
$48.26 - $68.88 $33,782 - $48,216
-700 Reduced 8.33%
7,704 $406,000
Q3 2018

Nov 13, 2018

BUY
$46.8 - $58.97 $393,307 - $495,583
8,404 New
8,404 $466,000
Q1 2018

May 14, 2018

SELL
$30.92 - $37.27 $159,639 - $192,425
-5,163 Closed
0 $0
Q4 2017

Feb 09, 2018

SELL
$32.53 - $38.92 $330,049 - $394,882
-10,146 Reduced 66.27%
5,163 $187,000
Q3 2017

Oct 20, 2017

BUY
$36.98 - $46.06 $566,126 - $705,132
15,309
15,309 $587,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.36B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.